Eric Aguiar's most recent trade in BridgeBio Pharma Inc was a trade of 5,277 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 5,277 | 5,277 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2026 | 3,990 | 10,579 (0%) | 0% | 0 | Common Stock | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 196,299 | 196,299 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 8,425 | 8,425 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 6,589 | 6,589 (0%) | 0% | 0 | Common Stock | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 91,970 | 91,970 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 26,014 | 26,014 | - | - | Stock Option (Right to Buy) | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 51,025 | 51,025 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 51,501 | 51,501 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 70,422 | 125,322 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 28,901 | 28,901 | - | - | Stock Option (right to buy) | |
| BridgeBio Pharma Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 104,921 | 104,921 | - | - | Stock Option (right to buy) | |
| Biomea Fusion Inc | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 23,867 | 23,867 | - | - | Stock Option (Right to Buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 32,100 | 43,600 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 16,100 | 16,100 | - | - | Stock Option (right to buy) | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 11,300 | 54,900 (0%) | 0% | 0 | Common Stock | |
| Invitae Corp | Eric Aguiar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 5,700 | 5,700 | - | - | Stock Option (right to buy) |